Clinical Trials Browser

Not yet recruiting × OTHER_GOV × pertuzumab × Clear all

NCT07047755 2025-07-02

Trastuzumab Rezetecan Plus Pertuzumab in the Neoadjuvant Treatment of HER2 Positive BC

Phase 2 Not yet recruiting

Breast Neoplasms